College of Pharmacy | Biopharmaceutical Sciences
College of Medicine | Ophthalmology and Visual Science
College of Engineering | Bioengineering | Chemical Engineering
UIC | OVCR | Research Integrity
Manuscripts | Book Chapters | Patents
Publications Google Scholar Scopus
  1. Zhang Y, Buhrman JS, Liu Y, Rayahin JE, Gemeinhart RA. Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid, Molecular Pharmaceutics, 13(6): 1791-1799, 2016. DOI & Pubmed
  2. Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D. Extended release of an anti-heparan sulfate peptide from a contact lens suppresses corneal Herpes Simplex Virus-1 (HSV-1) infection. Investigative Ophthalmology and Visual Science, 57(1): 169-180, 2016. DOI & Pubmed
  3. Lu Y, Chen Y, Gemeinhart RA, Wu W, Li T. Developing nanocrystals for cancer treatment, Nanomedicine, 10(16): 2537-2552, 2015. DOI & Pubmed
  4. Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA. High and low molecular weight hyaluronic acid differentially influence macrophage activation, ACS Biomaterials Science and Engineering, 1(7): 481-493, 2015. DOI & Pubmed
  5. Zhang Y, Liu Y Sen S, Král P, Gemeinhart RA. Charged Group Surface Accessibility Determines Micelleplexes Formation and Cellular Interaction, Nanoscale, 7(17): 7559-7564, 2015. DOI & Pubmed
  6. Rayahin JE, Buhrman JS, Gemeinhart RA. Melittin, as a glutathione S-transferase fusion protein, maintains anti-inflammatory properties while diminishing toxicity, European Journal of Pharmaceutical Sciences, 65(1): 112-121, 2014. DOI & Pubmed
  7. Zhang Y, Köllmer M, Buhrman JS, Tang MY, Gemeinhart RA. Arginine-rich, Cell Penetrating Peptide-microRNA Inhibitor Complexes Decrease Glioblastoma Migration Potential, Peptides, 58(1): 83-90, 2014. DOI & Pubmed
  8. Zellander A, Zhao H, Kotecha M, Low, K-B, Gemeinhart RA, Wardlow M, Abiade J, Cho M. Characterization of pore structure in biologically functional Poly(2-hydroxyethyl methacrylate)-poly(ethylene glycol) diacrylate (PHEMA-PEGDA), PLOS One, 9(5): e96709, 2014. DOI & Pubmed
  9. Sharma V, Köllmer M, Szymusiak M, Nitsche LC, Gemeinhart RA, Liu Y. Toroidal-spiral particles for co-delivery of anti-VEGFR-2 antibody and irinotecan-a potential implant to hinder recurrence of glioblastoma multiforme, Biomacromolecules, 15(3): 756-762, 2014. DOI & Pubmed
  10. Zhang H, Wang X, Dai W, Gemeinhart RA, Zhang Q, Li T. Pharmacokinetics and Treatment Efficacy of Camptothecin Nanocrystals on Lung Metastasis. Molecular Pharmaceutics. 11(1): 226-233, 2013. DOI & Pubmed
  11. Zhang Y, Wang ZJ, Gemeinhart RA. Progress in MicroRNA Delivery, Journal of Controlled Release, 172(3): 962-974, 2013. DOI & Pubmed
  12. Buhrman JS, Cook LC, Rayahin JE, Federle MJ, Gemeinhart RA. Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation. Biotechnology Progress, 29(5): 1150-1157, 2013. DOI & Pubmed
  13. Köllmer M, Popescu C, Manda P, Zhou L, Gemeinhart RA. Stability of Benzocaine Formulated in Commercial Oral Disintegrating Tablet Platforms. AAPS PharmSciTech, 14(4): 1333-1340, 2013. DOI & Pubmed
  14. Hollis CP, Weiss HL, Leggas M, Evers BM, Gemeinhart RA, Li T. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: Lessons learned of the EPR effect and image-guided drug delivery. Journal of Controlled Release, 172(1): 12-21, 2013. DOI & Pubmed
  15. Buhrman JS, Cook LC, Rayahin JE, Federle MJ, Gemeinhart RA. Proteolytically activated anti-bacterial hydrogel microspheres. Journal of Controlled Release, 171(3): 288-295. DOI & Pubmed
  16. Hollis CP, Weiss HL, Evers BM, Gemeinhart RA, Li T. In Vivo Investigation of Hybrid Paclitaxel Nanocrystals with Dual Fluorescent Probes for Cancer Theranostics. Pharmaceutical Research, 31(6): 1450-1459, 2014. . DOI & Pubmed
  17. Köllmer M, Buhrman JS, Zhang Y, Gemeinhart RA. Markers Are Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells. Journal of Developmental Biology and Tissue Engineering. 5(2): 18-25, 2013. DOI & Pubmed
  18. Zellander A, Gemeinhart RA, Djalilian AR, Makhsous M, Sun S, Cho MR. Desiging a Gas Foamed Scaffold for Keratoprosthesis. Material. Science and Engineering C-Materials for Biological Applications, 33(6): 3396-3406, 2013. DOI & Pubmed
  19. Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA. In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins. BMC Biotechnology, 12(1): 63, 2012. DOI & Pubmed
  20. Ross AE, Tang MY, Gemeinhart RA. Effects of Molecular Weight and Loading on Matrix Metalloproteinase-2 Mediated Release from Poly(Ethylene Glycol) Diacrylate Hydrogels. The AAPS Journal, 14(3): 482-490, 2012. DOI & Pubmed
  21. Zhang Y, Gemeinhart RA. Improving Matrix Metalloproteinase-2 Specific Response of a Hydrogel System using Electrophoresis. International Journal of Pharmaceutics, 429(1-2): 31-37, 2012. DOI & Pubmed
  22. Köllmer M, Keskar V, Hauk TG, Collins JM, Russell B, Gemeinhart RA. Stem Cell-derived Extracellular Matrix Enables Survival and Multi-Lineage Differentiation within Superporous Hydrogels. Biomacromolecules, 13(4): 963-973, 2012. DOI & Pubmed
  23. Rayahin JE, Buhrman JS, Gemeinhart RA. Hybrid Nanocrystals: University of Kentucky US 2006/0280680A1, Expert Opinion on Therapeutic Patents, 22(3): 341-348, 2012. DOI & Pubmed
  24. Desai ES, Tang MY, Ross, A, Gemeinhart RA. Macroporous Hydrogel Scaffolds: A Platform for Cell Encapsulation, Biomedical Materials, 7(2): 024108, 2012. DOI & Pubmed
  25. Shafiq MA, Gemeinhart RA, Yue BYJT, Djalilian AR. Decellularized Human Cornea for Reconstructing the Corneal Epithelium and Anterior Stroma, Tissue Engineering, Part C, 18(5): 340-348, 2012. DOI & Pubmed
  26. Zhao RS, Hollis CP, Zhang H, Sun L, Gemeinhart RA, and Li T. Hybrid Nanocrystals: Achieving Concurrent Therapeutic and Bioimaging Functionalities Toward Solid Tumors, Molecular Pharmaceutics, 8(5): 1985-1991, 2011. DOI & Pubmed
  27. Bae M, Divan R, Suthar KJ, Mancini DC, Gemeinhart RA. Fabrication of PEG Hydrogel Particles for Pharmaceutics using Electron beam and Optical Lithography, Journal of Vaccuum Science and Technology-B. 28(6): C6P24-C6P26, 2010. DOI & Pubmed
  28. Kadakia A, Keskar V, Djilian A, Gemeinhart RA, Cho MR. Materials Characterization of Hybrid Superporous Scaffolds, Critical Reviews in Biomedical Engineering. 36(5-6): 441-471, 2008. DOI & Pubmed
  29. Vartak DG, Lee BS, Gemeinhart RA. In vitro evaluation of functional interaction of integrin aνβ3 and matrix metalloprotease-2, Molecular Pharmaceutics, 6(6): 1856-1867, 2009. DOI & Pubmed
  30. Keskar V, Gandhi M, Gemeinhart EJ, Gemeinhart RA. Initial Evaluation of Vascular Ingrowth into Superporous Hydrogels, Journal of Tissue Engineering and Regenerative Medicine 3(6): 486-490, 2009. DOI & Pubmed
  31. Gandhi M, Srikar R, Yarin AL, Megaridis CM, Gemeinhart RA. Mechanistic Examination of Protein Release from Polymer Nanofibers, Molecular Pharmaceutics, 6(2): 641-647, 2009. DOI & Pubmed
  32. Keskar V, Marion NW, Mao JJ, Gemeinhart RA. In Vitro Evaluation of Macroporous Hydrogels to Facilitate Stem Cell Infiltration, Growth and Mineralization. Tissue Engineering, Part A. 15A(7): 1695-1707, 2009. DOI & Pubmed
  33. Gemeinhart RA. Digestive Enzyme Targeted Polymer Therapeutic:  MIT WO 2007/103364 A2. Expert Opinion on Therapeutic Patents. 18(9): 1085-1090, 2008. DOI
  34. Tauro JR, Lee BS, Lateef SS, Gemeinhart RA. Matrix Metalloprotease Selective Platinate Release from Hydrogel Matrices, Peptides. 29(11) 1965-1973, 2008. DOI & Pubmed
  35. Guo C, Gemeinhart RA. Investigation of the mechanism of chitosan adsorption to poly(lactide-co-glycolide) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 70(2): 597-604, 2008. DOI & Pubmed
  36. Chaterji S, Gemeinhart RA. Enhanced Osteoblast-Like Cell Adhesion and Proliferation Using Sulfated Polymeric Scaffold. Journal of Biomedical Materials Reserach. 83A(4): 990-998, 2007. DOI & Pubmed
  37. Vartak DG, Gemeinhart RA. Matrix metalloproteases: Underutilized Targets for Drug Delivery (Invited Review). Journal of Drug Targeting, 15(1): 1-20, 2007. DOI & Pubmed
  38. Keskar V, Mohanty, PS, Gemeinhart EJ, Gemeinhart RA. Development of a local system for treatment of cervical cancer. Journal of Controlled Release 115(3): 280-288, 2006. DOI & Pubmed
  39. Gemeinhart RA, Bare CM, Haasch RT, Gemeinhart EJ. Osteoblast-like cell attachment to and calcification of novel phosphate-containing polymeric substrates. Journal of Biomedical Materials Reserach. 78A(3): 433-440, 2006. DOI & Pubmed
  40. Muni NJ, Qian H, Qtaishat NM, Gemeinhart RA, Pepperberg DR. Activation of membrane receptors by neurotransmitter released from temperature-sensitivehydrogels. Journal of Neuroscience Methods. 151(2): 97-105, 2006. DOI & Pubmed
  41. Tauro JR, Gemeinhart RA. Matrix metalloprotease triggered local delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjugate Chemistry16(5): 1133-1139, 2005. DOI & Pubmed
  42. Tauro JR, Gemeinhart RA. Extracellular protease activation of chemotherapeutics from hydrogel matrices: A new paradigm for local chemotherapy. Molecular Pharmaceutics 2(5): 435-438, 2005. DOI & Pubmed
  43. Tauro JR, Gemeinhart RA. Development of amine-containing polymeric nanoparticles. Journal of Biomaterials Science, Polymer Edition 16(10): 1233-1244, 2005. DOI & Pubmed
  44. Yan X, Gemeinhart RA. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. Journal of Controlled Release 106(1-2): 198-208, 2005. DOI & Pubmed
  45. Gemeinhart RA, Luo D, Saltzman WM. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnology Progress 21(2): 532-537, 2005. DOI & Pubmed
  46. Tan J, Gemeinhart RA, Ma M, Saltzman WM. Improved cell adhesion and proliferation on synthetic phosphonic acid-containing hydrogels. Biomaterials 26(17): 3663-3671, 2005. DOI & Pubmed
  47. Kang CE, Gemeinhart EJ,Gemeinhart RA. Celluar alignment by grafted adhesion peptide surface density gradients. Journal of Biomedical Materials Research 71(3): 403-411, 2004. DOI & Pubmed
  48. Guo C, Gemeinhart RA. Assessment of a modular transfection mechanism based upon cellular localization of DNA. Molecular Pharmaceutics 1(4): 309-316, 2004. DOI & Pubmed
  49. Gemeinhart RA, Park H, Park K. Effect of compression on fast swelling of poly(acrylamide-co-acrylic acid) superporous hydrogels. Journal of Biomedical Materials Research 55(1): 54-62, 2001. DOI & Pubmed
  50. Gemeinhart RA, Chen J, Park H, Park K. pH-Sensitivity of fast responsive superporous hydrogels. Journal of Biomaterials Science, Polymer Edition 11(12): 1371-1380, 2000. DOI & Pubmed
  51. Gemeinhart RA, Park H, Park K. Pore structure of superporous hydrogels. Polymers for Advanced Technologies 11(8-12): 617-625, 2000. DOI
  52. Park K, Gemeinhart RA, Park H. Movement of fibrinogen receptors on the ventral membranes of spreading platelets. Biomaterials 19(4-5): 387-395, 1998. DOI & Pubmed
Book Chapters
  1. Zamiri C, Gemeinhart RA. Drug Delivery Systems for Pulmonary Delivery of Therapeutic Biomacromolecules, in Pharmaceutical Biotechnology, Second Edition, Ed. Groves MJ. Boca Raton, FL: CRC Press; 2005, 255-277.
  2. Gemeinhart RA. Polymers for Oral Biomolecule Delivery, in Pharmaceutical Biotechnology, Second Edition, Second Edition, Ed. Groves MJ. Boca Raton, FL: CRC Press; 2005, 279-302.
  3. Gemeinhart RA, Guo C. Fast Swelling Hydrogel Systems, in Reflexive polymers and hydrogels: Understanding and designing fast-responsive polymeric systems, edited by Yui N, Mrsny R, Park K, 2004.
  4. Rayahin JE, Gemeinhart RA. Activation of Macrophages in Response to Biomaterials. In: Kloc M (ed) Macrophages - Origin, functions and biointervention part of the Results and problems in cell differentiation series. Springer, New York. 2017, Volume 62, Chapter 13, 317-351. DOI
Patents
  1. Gemeinhart RA, Buhrman JS, Rayahin JE. Hydrogels for Delivery of Therapeutic Polypeptides, US 9,457,101B2 (October 4, 2016). USPTO
  2. Cho MR, Kadakia A, Djilian A, Gemeinhart RA. Hybrid Superporous Hydrogel Scaffold for Cornea Regeneration. Patent Application, 2010/80,840A1 (April 1, 2010). USPTO
  3. Gemeinhart RA. Superporous Hydrogel with Cells Encapsulated Therein and Method for Producing the Same. US 8,414,879B2 (April 9, 2013). USPTO
  4. Gemeinhart RA, Tauro JR. Composition and Method for Providing Localized Delivery of a Therapeutic Agent. US 7,943,569 (May 17, 2011). USPTO
Input Richard A. Gemeinahrt: BPS, College of Pharmacy in Other
Designed and implemented by R. A. Gemeinhart, Ph.D. All rights researved. © 2001-2011 Last Modified: 10/20/2011
DISCLAIMER: The opinions and links of this page and all pages maintained by Rick Gemeinhart are in no way representative of The University of Illinois, the Departments of Biopharmaceutical Sciences, Bioengineering, or Ophthalmology and Visual Sciences, the Colleges of Engineering, Medicine or Pharmacy or anyone other than the Rick Gemeinhart. These pages are for the dissemination of information from the Gemeinhart Research Group, and should not be reproduced for any purpose other than for personal or educational use.

Inspired by many websites online, but in particular those implemented by Tonglei Li (http://xtal.gws.uky.edu/).
back to top